Effects of sildenafil treatment on patients with Peyronie's disease and erectile dysfunction


Ozturk U., Yesil S. , Goktug H. N. G. , Gucuk A., Tuygun C., Sener N. C. , ...Daha Fazla

IRISH JOURNAL OF MEDICAL SCIENCE, cilt.183, ss.449-453, 2014 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 183 Konu: 3
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1007/s11845-013-1036-5
  • Dergi Adı: IRISH JOURNAL OF MEDICAL SCIENCE
  • Sayfa Sayıları: ss.449-453

Özet

It has been shown on experimental rat models that type 5-phosphodiesterase isoenzyme (PDE5) inhibitors have anti-fibrotic effects for Peyronie's disease (PD); however, this issue has not been addressed clinically. The aim of this study was to document the effects of PDE5 inhibitors used for erectile dysfunction (ED) seen in PD patients on the main course of the PD clinically.